Abstract
The therapeutic effectiveness of a combination therapy — pretreatment with transcatheter arterial chemoembolization (TACE) followed by percutaneous ethanol injection (PEI) therapy — for large (>3 cm in diameter) unresectable hepatocellular carcinoma (HCC) wa compared with that of TACE alone. PEI therapy was performed in 24 cases of unresectable HCC that had previously been treated with TACE using doxorubicin 30–60 mg or epirubicin 50–90 mg. In all, 2–10 ml of 90% ethanol mixed with carbocaine was repeatedly injected through a 21-gauge, closed-end needle (PEIT needle) for a median of 3.6 injections and 31.1 ml of ethanol. As adverse effects, transient localized pain and a burning sensation were observed in 75.0% of the cases; fever, in 66.7%; and transient hypotension, in two cases. A small unresectable tumor is a good indication for PEI therapy. In cases with a larger tumor, i.e., measuring more than 3 cm in diameter, or multiple tumors, the 1-year survival rate obtained with this combination therapy, i.e., TACE and PEI, was 87.0%, and the 2-year survival rate was 65.2%. These rates were greater than those obtained with TACE alone. Accordingly, additional PEI therapy was effective for larger tumors and multiple tumors previously treated with TACE.
Similar content being viewed by others
References
Akamatsu K, Miyauchi S, Itoh Y (1991) Advancement of US-guided fine needle biopsy and ethanol injection therapy for small hepatocellular carcinoma. JSUM Proc 1991: 47
Fujimoto T (1988) Experimental and clinical studies of percutaneous ethanol injection therapy (PEIT) under ultrasonography for small hepatocellular carcinoma. Acta Hepatol Jpn 29: 52
Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C (1976) Transcatheter occulusion of abdominal tumors. Radiology 120: 539
Liver Cancer Study Group of Japan (1987) Primary liver cancer in Japan. Cancer 60: 1400
Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G (1992) Percutaneous alcohol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 69: 925
Nakamura H, Hashimoto Y, Oi H, Sawada S (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170: 783
Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 54: 387
Sheu JC, Sung JL, Huang GT, Chen JC, Yang PM, Lai MY, Wei TC, Su CT, Tsang YM, Lee CZ, Chen JC, Hsu HC (1987) Intratumor injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Hepatogastroenterology 34: 255
Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Niwa Y, Hata Y, Komatsu Y, Shiratori Y, Terano A, Sugimoto T (1990) Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. AJR 154: 947
Sugiura N, Takara K, Ohto M, Okuda K, Hirroka N (1983) Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 24: 920
Tanaka K, Okazaki H, Nakamura S, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y (1991) Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 179: 713
Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y (1992) Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185: 457
WHO (1983) Prevention of primary liver cancer. Report on a meeting of a W.H.O. scientific group. Lancet 26: 463
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1983) Hepatic arterial embolization in 120 patients with unresectable hepatoma. Radiology 148: 397
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kato, T., Saito, Y., Niwa, M. et al. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma. Cancer Chemother. Pharmacol. 33 (Suppl 1), S115–S118 (1994). https://doi.org/10.1007/BF00686681
Issue Date:
DOI: https://doi.org/10.1007/BF00686681